SCHEMBL15528512

SCHEMBL15528512

N#Cc1ccc2c(c1)C=NC2

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.51
PNMT P11086 6/20 0.41
DRD2 P14416 4/20 0.41
DRD3 P35462 4/20 0.41
KDM1A O60341 2/20 0.36
CYP19A1 P11511 2/20 0.34
CA12 O43570 1/20 0.33
CA9 Q16790 1/20 0.33
CYP11B1 P15538 1/20 0.33
CYP11B2 P19099 1/20 0.33
CHRNA1 P02708 1/20 0.32
CHRNG P07510 1/20 0.32
CHRNB1 P11230 1/20 0.32
CHRNB2 P17787 1/20 0.32
CHRNB4 P30926 1/20 0.32
CHRNA3 P32297 1/20 0.32
CHRNA4 P43681 1/20 0.32
CHRND Q07001 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27582463 0.98 TRPA1 (0.50) TRPA1PNMTDRD2DRD3KDM1A
SCHEMBL28331918 0.81 TRPA1 (0.49) TRPA1PNMTDRD2DRD3KDM1A
SCHEMBL3296947 0.74 DRD2 (0.42) TRPA1PNMTDRD2DRD3KDM1A
SCHEMBL26710938 0.73 TRPA1 (0.48) TRPA1PNMTDRD2DRD3KDM1A
SCHEMBL148119 0.71 CA1 (0.44) TRPA1PNMTDRD2DRD3KDM1A
SCHEMBL29740368 0.71 CA1 (0.44) TRPA1PNMTDRD2DRD3KDM1A
SCHEMBL29740370 0.71 CA1 (0.44) TRPA1PNMTDRD2DRD3KDM1A
SCHEMBL16406926 0.70 MEN1 (0.46)
SCHEMBL32680680 0.70 CYP11B1 (0.43) TRPA1PNMTDRD2DRD3KDM1A
SCHEMBL27984426 0.70 CYP11B1 (0.43) TRPA1PNMTDRD2DRD3KDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2855456-A1 COMPLEMENT PATHWAY MODULATORS AND USES THEREOF Novartis AG (CH) 2015-04-08 EP disclosed
WO-2013164802-A1 COMPLEMENT PATHWAY MODULATORS AND USES THEREOF NOVARTIS AG (CH) 2013-11-07 WO disclosed